Rechanneling the Current Cardiac Risk Paradigm: Arrhythmia Risk Assessment During Drug Development Without the Thorough QT Study
July 23, 2013
Silver Spring, Maryland, USA
July 23, 2013
Silver Spring, Maryland, USA
June 11, 2013 – June 13, 2013
Alexandria, Virginia, USA
Meeting participants learned about HESI’s role in translating science from research to application, shared perspectives on current and pending scientific challenges, and engaged in interactive discussions that will help influence HESI’s future scientific direction.
May 16, 2013 – May 17, 2013
Paris, France
This workshop was held on 16-17 May 2013 at OECD Congress Center in Paris, France, with the goal to review progress in human carcinogenesis safety evaluation strategies and cancer risk assessment.
May 7, 2013 – May 8, 2013
Arlington, Virginia, USA
The 7-8 May 2013 Biotechnology Update Symposium in Arlington, VA, was co-sponsored by the HESI Protein Allergenicity Technical Committee (PATC) and the ILSI International Food Biotechnology Committee (IFBiC).
April 15, 2013 – April 16, 2013
Beijing, China
The 15-16 April 2013 Food Allergy and Safety Assessment Workshop in Beijing, China, was co-sponsored by the HESI Protein Allergenicity Technical Committee, the ILSI Focal Point in China, the ILSI International Food Biotechnology Committee (IFBiC), the China National Center for Food Safety Risk Assessment, and the China ...
March 18, 2013 – March 19, 2013
Cambridge, Massachusetts, USA
This workshop was co-sponsored by co-sponsored by the HESI Cardiac Safety Technical Committee and the Safety Pharmacology Society.
hesi@hesiglobal.org
Phone: +1-202-659-8404
Fax: +1-202-659-3859
740 15th Street NW, Suite 600
Washington, DC 20005
Sign up for our monthly e-newsletter.